All data are based on the daily closing price as of April 22, 2025
o

Otsuka Holdings

4578.TSE
47.22 USD
0.18
+0.38%

Overview

Last close
47.22 usd
Market cap
25.01B usd
52 week high
61.79 usd
52 week low
34.98 usd
Target price
64.97 usd

Valuation

P/E
10.3975
Forward P/E
13.986
Price/Sales
1.548
Price/Book Value
1.3232
Enterprise Value
23.84B usd
EV/Revenue
1.4371
EV/EBITDA
7.3977

Key financials

Revenue TTM
16.59B usd
Gross Profit TTM
11.89B usd
EBITDA TTM
3.73B usd
Earnings per Share
4.51 usd
Dividend
0.85 usd
Total assets
23.92B usd
Net debt
-1.51B usd

About

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products. In addition, the company offers IT solution services; adhesive tapes; flaky titanate and compounds; IV solutions; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; urinary tract health products; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.
  • Symbol
    4578.TSE
  • Exchange
    TSE
  • Isin
    JP3188220002
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - General
  • CEO
    Mr. Tatsuo Higuchi
  • Headquarter
    Tokyo
  • Web site
    https://www.otsuka.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top